A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

The Wacker Biotechnology Center is in Munich, where the company has been conducting fundamental research for over a century.

Wacker Chemie A.G. has opened an expanded, "double-digit millions of dollars" facility for biotechnology research in food and ...

The messenger ribonucleic acid (mRNA) COVID-19 vaccines developed by CSPC Pharmaceutical Group is showcased at the exhibition hall of Shijiazhuang International Biomedical Park in Shijiazhuang, Hebei ...

DelveInsight's, “Melanoma Pipeline Insight” report provides comprehensive insights about 150+ companies and 170+ pipeline ...

The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.

Nearly 150 new Florida laws went into effect on July 1 after Gov. Ron DeSantis signed 11 more the day before. Here is what ...

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...

Research shows that small extracellular vesicles shed by donor heart cells and circulating T cells provide a precise readout ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most active stocks to buy according to analysts. On June 13, Ethris announced a collaboration with Thermo Fisher Scientific. The partnership aims ...

Ethris has entered a strategic partnership with Thermo Fisher Scientific for providing completely integrated mRNA solution.

CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.